FDA approves an Ebola vaccine, long in development, for the first time – STAT
The vaccine, developed by Merck, protects against Zaire ebolaviruses, the species of the virus that has been the most common cause of Ebola outbreaks.
Related Articles
A husband and wife photographed each other during her cancer journey. Here is what they learned
When Anna Rathkopf was diagnosed with breast cancer, she and her husband, Jordan, tried to be strong for each other. But their photographs showed what…
With the U.S. gone, WHO nations will increase contributions
And more health news you need to read this morning.
Three big ideas to actually ‘Make America Healthy Again’
STAT reviewed dozens of studies, interviewed chronic disease experts, and landed on three focus areas for Robert F. Kennedy Jr. to boost health.
RFK Jr. declared war on chronic disease. First comes the battle over priorities
How would you solve the chronic disease epidemic? Here’s STAT’s extensive new data analysis, and nine ways to tackle the problem.
Trump, building on Biden policy, to speed up audits of Medicare Advantage insurers
CMS will hire nearly 2,000 coders to conduct audits to confirm diagnoses used for payment are backed by medical records.
Five burning questions on the FDA’s new Covid-19 vaccine framework
FDA’s Covid vaccine policy raises concerns over access, trial requirements, and transparency.
LGBTQ+ researchers sue HHS, NIH over grant cuts
The suit, filed Tuesday in the U.S. District Court for the District of Maryland, charges that cutting $800 million in medical research endangers lives.
What is WHO without the U.S.? Health officials wrestle with future at annual meeting
As WHO pares back staff and programs after loss of U.S. funding, health officials wrestled with its purpose and future.
Civica touts a study that ‘validates’ its model for selling low-cost generics
Civica Script is touting a new study that it says validates its model for selling low-cost generics.
How do we know mRNA vaccines are safe and effective? An explainer
This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here’s an explainer of how we know they are safe and…